Neurology® Podcast

Dr. Gordon Smith talks with Dr. Charlotte Sumner about spinal muscular atrophy, highlighting the historic milestone reached with three medications receiving FDA approval for the treatment of SMA.

Dr. Jason Crowell talks with Drs. Ariane Lewis and David Magnus about the need to update the Uniform Declaration of Death Act (UDDA), aligning the legal criteria with the medical standards used to determine death by neurological criteria. Read the full article in Neurology.

Dr. Alex Menze talks with Dr. Raquel Gardner about the development of a clinically-relevant definition of poor cognitive outcome one year after mild traumatic brain injury (mTBI) and whether outcomes can be predicted by baseline clinical variables. Read the full article in Neurology.

This episode features Dr. Stacey Clardy in conversation with the 2022 Ted Burns Humanism in Neurology Award Winner, Dr. Barbara Giesser.

Dr. Gregg Day talks with Dr. Niklas Mattsson-Carlgren about the correlation of cerebrospinal fluid biomarkers with autopsy-confirmed Alzheimer disease and frontotemporal lobar degeneration. Read the full article in Neurology.

Dr. Jeff Ratliff talks with Dr. Christos Ganos about the use of brain lesion network mapping to interrogate whether tic disorder-inducing lesions are associated with a common network in the average human brain.

Dr. Jason Crowell talks with 46brooklyn Research CEO Antonio Ciaccia about how Medicare Part D has hidden the benefits of generic competition for Tecfidera, a disease-modifying therapy for multiple sclerosis. Read the full article at 46brooklyn.com.

The March 2022 replay of past episodes showcases a selection of interviews regarding the prognosis and treatment of Guillain-Barré syndrome. This episode features Drs. Ted Burns, Jeff Ratliff, and Michelle Mauermann in conversation with Dr. Bart Jacobs over the course of a decade, highlighting the progress he and his team have made in treating and predicting outcomes in GBS over time.

Dr. Tesha Monteith talks with Dr. Elizabeth Loder about her editorial on the gender pay gap in academic neurology and its impact on women neurologists as well as the field at large. Read the full article in Neurology.

Dr. Andy Southerland talks with Dr. Daniel Chasman about the shared genetic risk of migraine, stroke, and cervical artery dissection (CeAD), a triad of neurologic disorders with vascular involvement. Read the full article in Neurology: Genetics.

Dr. Halley Alexander discusses whether epilepsy type, seizure location, or antiseizure medications influence seizure frequency during pregnancy and postpartum with Dr. P. Emanuela Voinescu. Read the full article in Neurology. 

Dr. Stacey Clardy discusses the clinical, biological, and imaging features—as well as the overall clinical course—of a French cohort of patients with glial fibrillar acidic protein (GFAP) autoantibodies with Dr. Jérôme Honnorat. Read the full article in Neurology. 

Dr. Justin Abbatemarco talks with Dr. Daniel Hartung about the impact of Medicare Part D plan disease-modifying therapy restrictiveness upon adherence and outcomes among patients with multiple sclerosis. Read the full article in Neurology: Clinical Practice.

Dr. Jeff Ratliff talks with Dr. Bart Jacobs about his study on the validity and region-specificity of the modified Erasmus GBS Outcome Score in predicting the risk of walking inability in patients with Guillain-Barré syndrome. Read the full article in Neurology. 

Dr. Stacey Clardy interviews behavioral neurologist Dr. Daniel Drubach about his experience with being diagnosed with Lewy body dementia, highlighting the unique perspective his diagnosis has provided him as a physician and as a patient. Read Dr. Drubach's special article in Continuum: "Twilight and Me: A Soliloquy." 

The February 2022 replay of past episodes showcases a selection of interviews regarding the diagnosis and treatment of immune-mediated neuropathies. This episode features Drs. Stacey Clardy and Ted Burns in conversation with Drs. Luise Appeltshauser, Shahar Shelly, and P. James B. Dyck, offering listeners essential insight into the identification and management of acute autoimmune neuropathy, chronic immune sensory polyradiculopathy, and lumbrosacral radiculoplexus neuropathy.

Dr. Jason Crowell talks with Pulitzer Prize-winning New York Times journalist Pam Belluck about the impact of Medicare’s decision to limit patient access to aducanumab for the treatment of Alzheimer disease, restricting use to individuals in clinical trials.